Kirkland Advises Oak Street Health, Inc. on $10.6 Billion Sale to CVS Health
Kirkland & Ellis advised Oak Street Health (NYSE: OSH), a leading multi-payor, value-based primary care company, on its sale to CVS Health® (NYSE: CVS) in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion. With an innovative care model and technology platform designed to deliver consistently superior outcomes and patient experiences, Oak Street Health has demonstrated that its model is scalable. Bringing CVS Health and Oak Street Health together can significantly benefit patients’ long-term health by reducing care costs and improving outcomes, particularly for those in underserved communities.
Read the transaction press release
The Kirkland team was led by corporate partners David Klein, Daniel Wolf and Josh Ayal and associates Julia Knafo and Inhae Song; executive compensation partners Stephen Jacobson and Stephanie Jeane and associate Karsten Busby; antitrust partner Andrea Murino and associates Jack Coles and Chris Brassfield; capital markets partner Robert Goedert; tax partner Roger Lucas and associate Alex Stephenson; and healthcare partners Dennis Williams and Anthony Del Rio.
